ARHGEF16 and malignant colon neoplasm: Although additional studies are needed to understand whether the FYN-ARHGEF16 signaling axis promotes colon cancer progression through some other mechanisms and whether this axis works in other tumors, our current study offers useful information for future precision oncology with a new biomarker for this type of cancer.